Posted inResearch
PhaseV launches trial optimization software into CRO Bioforum’s offerings
Clinical software developer PhaseV is teaming up with another global CRO, unveiling a plan to infuse its trial design platform…
Posted inResearch
Australian biotech Filamon partners with Pi Health for anti-inflammatory cancer trial
Global CRO Pi Health has pulled a new partnership out of the oven. Building on a growing presence Down Under,…
Posted inResearch
Amgen looks to level up clinical trials with Veeva Systems partnership
Veeva Systems has unveiled its first big biotech pact since thawing relations with one-time adversary IQVIA, teaming up with Amgen…
Posted inResearch
Chinese CRO ChemPartner gets ready to debut new Boston research facility
Chinese contract research and manufacturing outfit ChemPartner is building out its U.S. footprint in the heart of the bustling Boston…
Posted inResearch
IQVIA and Veeva go from adversaries to friends, ending legal spat and forming long-term pact
The yearslong legal kerfuffle between IQVIA and Veeva Systems has come to a close, with the former adversaries setting aside…
Posted inResearch
FDA draft recommends overall survival data collection for all cancer trials
More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in…
Posted inResearch
Private equity firm acquires clinical trial site network Headlands Research
After years of striking acquisitions to build up its site network, Headlands Research has now been bought itself. Headlands has…
Posted inResearch
Medidata elevates Amgen vet Moneymaker to lead business strategy
Clinical trial tech outfit Medidata has elevated a new strategy leader from within. Industry veteran Lisa Moneymaker will now guide…
Posted inResearch
West Virginia University Cancer Institute finds place it belongs in Ryght AI site network
Ryght AI traveled down country roads to find the newest member of its growing clinical trial site collection. West Virginia…
Posted inResearch
Charles River collaboration aims to bring crowdfunding to early-stage cell and gene biotechs
After launching an expanded incubator for early-stage biotechs late last year, Charles River Laboratories is now looking to give participants…